To participate in a fast-growing but competitive and complicated market, GLP-1 originators will need to adopt a differentiated patient- and customer-centric strategy leveraging both internal and external resources to optimize product positioning, building brand equity, integrating software and device solutions beyond the drug itself, and exploring innovative channels
168 However, the possibility of DDIs related to delayed gastric emptying cannot be excluded, 175 so investigators recommend monitoring when oral drugs are co-administered with GLP-1 RAs and a dual GLP-1/GIP RA
If the question is "which peptide can I add to my existing stack without significant systemic disruption," AOD 9604 is the answer
Start with 1 teaspoon daily mixed in at least 812 oz of water
Right now, many peptides people are interested in taking are restricted--theyre on the FDAs Category 2 bulk substance list, which means they are not eligible for compounding by compounding pharmacies
S2CID 231943836
